Lv1
78 积分 2025-11-11 加入
Real-World Comparative Analysis of Polatuzumab Vedotin-Based Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone versus Standard Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study
1个月前
已完结
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma
6个月前
已完结
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma
6个月前
已关闭
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma
6个月前
已完结
皖公网安备34019202002308
